Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ANIP
GENB
Add up to 3 more stocks
ANIP
ANI Pharmaceuticals, Inc.
-1.32%
$71.63-0.95Delayed quote: Oct 6, 2026, 11:15 AM EDT
Market Cap
$1.63B
52W Range
$69.58 - $97.00
GENB
Generate Biomedicines, Inc.
+0.29%
$13.95+0.04Delayed quote: Oct 6, 2026, 11:15 AM EDT
Market Cap
$1.79B
52W Range
$11.00 - $22.67
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 15.47 | N/A |
| Forward P/E | 7.72 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.73 | 3.92 |
| P/S Ratio | 1.66 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | 6.77 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 51.0% | 100.0% |
| Operating Margin | 15.3% | -737.0% |
| Net Margin | 10.8% | -637.0% |
| ROE | 17.7% | N/A |
| ROA | 7.1% | -61.5% |
| ROIC | 9.3% | -94.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.91 | 8.30 |
| Quick Ratio | 2.41 | 8.30 |
| Debt/Equity | 0.55 | 0.14 |
| Interest Coverage | 4.05 | -206.92 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.